Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density

Journal of Bone and Mineral Research

Volumn 30, Issue 6, 2015, Pages 985-991

  Dalbeth, Nicola ^a   Topless, Ruth ^b   Flynn, Tanya ^b   Cadzow, Murray ^b   Bolland, Mark J ^a   Merriman, Tony R ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

BONE; GENETIC; MENDELIAN RANDOMIZATION; URATE

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER 4; SODIUM PHOSPHATE COTRANSPORTER 1; URATE; URATE TRANSPORTER; CARRIER PROTEIN; URIC ACID;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EFFECT SIZE; FEMALE; FEMUR NECK; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; OBSERVATIONAL STUDY; REGRESSION ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; URIC ACID BLOOD LEVEL; BLOOD; CLINICAL TRIAL; GENETICS; METABOLISM; MULTICENTER STUDY;

ADULT; BONE DENSITY; FEMALE; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; URIC ACID;

EID: 84929326829     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2434     Document Type: Article

References (30)

1. Nabipour I, Sambrook PN, Blyth FM, et al., Serum uric acid is associated with bone health in older men: A cross-sectional population-based study. J Bone Miner Res. 2011; 26: 955-64.
2. Sritara C, Ongphiphadhanakul B, Chailurkit L, Yamwong S, Ratanachaiwong W, Sritara P,. Serum uric acid levels in relation to bone-related phenotypes in men and women. J Clin Densitom. 2013; 16: 336-40.
3. Ahn SH, Lee SH, Kim BJ, et al., Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women. Osteoporos Int. 2013; 24: 2961-70.
4. Lane NE, Parimi N, Lui L, et al., Association of serum uric acid and incident nonspine fractures in elderly men: The Osteoporotic Fractures in Men (MrOS) Study. J Bone Miner Res. 2014; 29: 1701-7.
5. Makovey J, Macara M, Chen JS, et al., Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: A longitudinal study. Bone. 2013; 52: 400-6.
6. Ishii S, Miyao M, Mizuno Y, Tanaka-Ishikawa M, Akishita M, Ouchi Y,. Association between serum uric acid and lumbar spine bone mineral density in peri- and postmenopausal Japanese women. Osteoporos Int. 2014; 25: 1099-105.
7. Kim BJ, Baek S, Ahn SH, et al., Higher serum uric acid as a protective factor against incident osteoporotic fractures in Korean men: A longitudinal study using the National Claim Registry. Osteoporos Int. 2014; 25: 1837-44.
8. Bonora E, Targher G, Zenere MB, et al., Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord. 1996; 20: 975-80.
9. McAdams DeMarco MA, Maynard JW, Baer AN, et al., Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: The Atherosclerosis Risk in Communities cohort study. Arthritis Rheum. 2012; 64: 121-9.
10. Sumino H, Ichikawa S, Kanda T, Nakamura T, Sakamaki T,. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet. 1999; 354: 650.
11. Khanna D, Fitzgerald JD, Khanna PP, et al., American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken). 2012; 64: 1431-46.
12. Sundy JS, Baraf HS, Yood RA, et al., Efficacy, tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: Two randomized controlled trials. JAMA. 2011; 306: 711-20.
13. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G,. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008; 27: 1133-63.
14. Lyngdoh T, Vuistiner P, Marques-Vidal P, et al., Serum uric acid and adiposity: Deciphering causality using a bidirectional Mendelian randomization approach. PLoS ONE. 2012; 7: e39321.
15. Palmer TM, Nordestgaard BG, Benn M, et al., Association of plasma uric acid with ischaemic heart disease, blood pressure: Mendelian randomization analysis of two large cohorts. BMJ. 2013; 347: f4262.
16. Hughes K, Flynn T, de Zoysa J, Dalbeth N, Merriman TR,. Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function. Kidney Int. 2014; 85: 344-51.
17. Rasheed H, Hughes K, Flynn TJ, Merriman TR,. Mendelian randomization provides no evidence for a causal role of serum urate in increasing serum triglyceride levels. Circ Cardiovasc Genet. 2014; 7: 830-7.
18. Palmer TM, Lawlor DA, Harbord RM, et al., Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012; 21: 223-42.
19. Kottgen A, Albrecht E, Teumer A, et al., Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet. 2013; 45: 145-54.
20. Fox J, Nie Z, Byrnes J,. Sem: Structural equation models. R package version 3. 2014; 1-5. http://cran.r-project.org/package.
21. Lesnoff M, Lancelot R,. Aod: Analysis of overdispersed data. R package version 1.3. 2012; http://cran.r-project.org/package.
22. Li Y, Ding J, Abecasis GR,. Mach 1.0: Rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet. 2006; 79: S2290.
23. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D,. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006; 38: 904-9.
24. Hausman JA,. Specification tests in econometrics. Econometrica. 1978; 46: 1251-71.
25. Brion MJ, Shakhbazov K, Visscher PM,. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013; 42: 1497-501.
26. Kolz M, Johnson T, Sanna S, et al., Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009; 5: e1000504.
27. Glymour MM, Tchetgen EJ, Robins JM,. Credible Mendelian randomization studies: Approaches for evaluating the instrumental variable assumptions. Am J Epidemiol. 2012; 175: 332-9.
28. Staiger D, Stock J,. Instrumental variables regression with weak instruments. Econometrica. 1997; 65: 557-86.
29. Fetsch PA, Abati A, Litman T, et al., Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. Cancer Lett. 2006; 235: 84-92.
30. Burgess S, Thompson SG,. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011; 40: 755-64.